Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Intrinsic Value
Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. [ Read More ]
The intrinsic value of one
Eyebright Medical Technology Beijing Co Ltd
stock under the Base Case scenario is
99.93
CNY.
Compared to the current market price of 150.45 CNY,
Eyebright Medical Technology Beijing Co Ltd
is
Overvalued by 34%.
Eyebright Medical Technology Beijing Co Ltd's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
Eyebright Medical Technology Beijing Co Ltd or that its price is influenced by factors unrelated to fundamentals.
Eyebright Medical Technology Beijing Co Ltd's market capitalization is 15.8B CNY.
Eyebright Medical Technology Beijing Co Ltd stock price is 150.45 CNY.
Eyebright Medical Technology Beijing Co Ltd stock (99.93 CNY) is 34% less than its price (150.45 CNY).
Eyebright Medical Technology Beijing Co Ltd stock (117.22 CNY) is 22% less than its price (150.45 CNY). Open DCF Valuation
Eyebright Medical Technology Beijing Co Ltd stock (82.64 CNY) is 45% less than its price (150.45 CNY). Open Relative Valuation
Eyebright Medical Technology Beijing Co Ltd has upside potential of 45% compared to the average analyst price target.
Open Wall St Estimates
Eyebright Medical Technology Beijing Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 12% to 15%.
Eyebright Medical Technology Beijing Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 15%.
Eyebright Medical Technology Beijing Co Ltd has positive three-year average ROE (Return on Equity): 12%. The company is efficient at transforming stockholders' equity into net income.
Eyebright Medical Technology Beijing Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 12% to 18%.
Eyebright Medical Technology Beijing Co Ltd has positive three-year average ROIC (Return on Invested Capital): 13%. The company is efficient at using invested capital to generate operating income.
Eyebright Medical Technology Beijing Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 18%.
Eyebright Medical Technology Beijing Co Ltd's Revenue has grown by an exceptional 43% over the past 12 months.
Eyebright Medical Technology Beijing Co Ltd has positive Net Income for the last twelve months.
Eyebright Medical Technology Beijing Co Ltd's Revenue is forecast to grow at a rate of 44% per year over the next 3 years.
Eyebright Medical Technology Beijing Co Ltd has positive Operating Income for the last twelve months.
Eyebright Medical Technology Beijing Co Ltd has positive Gross Profit for the last twelve months.
Eyebright Medical Technology Beijing Co Ltd has negative Free Cash Flow for the last twelve months.
Eyebright Medical Technology Beijing Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.09.
Eyebright Medical Technology Beijing Co Ltd's short-term assets (1B CNY) exceed its short-term liabilties (121m CNY).
Eyebright Medical Technology Beijing Co Ltd's long-term assets (2B CNY) exceed its long-term liabilties (374m CNY).
Eyebright Medical Technology Beijing Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (733m CNY) than debt (171m CNY).
Eyebright Medical Technology Beijing Co Ltd's Altman Z-Score is very high and is equal to 35.8.
Valuation Backtest
Eyebright Medical Technology Beijing Co Ltd
Run backtest to discover the historical profit from buying and selling
Eyebright Medical Technology Beijing Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Eyebright Medical Technology Beijing Co Ltd
Balance Sheet Decomposition
Eyebright Medical Technology Beijing Co Ltd
| Current Assets | 1.1B |
| Cash & Short-Term Investments | 733.2m |
| Receivables | 168.4m |
| Other Current Assets | 166.9m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 160.1m |
| PP&E | 868.5m |
| Intangibles | 168.6m |
| Other Non-Current Assets | 92.9m |
| Current Liabilities | 120.6m |
| Accounts Payable | 19m |
| Accrued Liabilities | 33.7m |
| Other Current Liabilities | 67.9m |
| Non-Current Liabilities | 253.3m |
| Long-Term Debt | 171.2m |
| Other Non-Current Liabilities | 82.2m |
Earnings Waterfall
Eyebright Medical Technology Beijing Co Ltd
|
Revenue
|
713.4m
CNY
|
|
Cost of Revenue
|
-127.9m
CNY
|
|
Gross Profit
|
585.4m
CNY
|
|
Operating Expenses
|
-309.8m
CNY
|
|
Operating Income
|
275.6m
CNY
|
|
Other Expenses
|
-2.9m
CNY
|
|
Net Income
|
272.7m
CNY
|
Free Cash Flow Analysis
Eyebright Medical Technology Beijing Co Ltd
Profitability Score
Profitability Due Diligence
Eyebright Medical Technology Beijing Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Eyebright Medical Technology Beijing Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Eyebright Medical Technology Beijing Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Eyebright Medical Technology Beijing Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Eyebright Medical Technology Beijing Co Ltd
According to Wall Street analysts, the average 1-year price target for
Eyebright Medical Technology Beijing Co Ltd
is 218.79 CNY
with a low forecast of 175.25 CNY and a high forecast of 252 CNY.
Shareholder Return
Price
Eyebright Medical Technology Beijing Co Ltd
| Average Annual Return | 0.82% |
| Standard Deviation of Annual Returns | 26.45% |
| Max Drawdown | -69% |
| Market Capitalization | 15.8B CNY |
| Shares Outstanding | 105 250 992 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Eyebright Medical Technology Beijing Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. The company is headquartered in Beijing, Beijing and currently employs 579 full-time employees. The company went IPO on 2020-07-29. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The firm conducts its businesses in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Eyebright Medical Technology Beijing Co Ltd
stock under the Base Case scenario is
99.93
CNY.
Compared to the current market price of 150.45 CNY,
Eyebright Medical Technology Beijing Co Ltd
is
Overvalued by 34%.
You don't have any saved screeners yet
